Reported 20 days ago
UnitedHealth Group's stock fell for the second consecutive day, dropping 5.1% following the murder of CEO Brian Thompson. This decline is attributed to a backlash over the company's insurance practices, particularly high denial rates. Despite some analysts raising their price targets due to previous guidance, social media outrage and potential calls for regulatory change are impacting investor sentiment.
Source: YAHOO